Page 109 - Read Online
P. 109

Noor et al. Neuroimmunol Neuroinflammation 2019;6:10  I  http://dx.doi.org/10.20517/2347-8659.2019.18                Page 31 of 32

                   muridarum genital tract infection. PLoS Pathog 2013;9:e1003707.
               70.  Murphy PG, Ramer MS, Borthwick L, Gauldie J, Richardson PM, et al. Endogenous interleukin-6 contributes to hypersensitivity to
                   cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 1999;11:2243-53.
               71.  Shimoyama M, Tanaka K, Hasue F, Shimoyama N. A mouse model of neuropathic cancer pain. Pain 2002;99:167-74.
               72.  Jancalek R. Signaling mechanisms in mirror image pain pathogenesis. Ann Neurosci 2011;18:123-7.
               73.  Spataro LE, Sloane EM, Milligan ED, Wieseler-Frank J, Schoeniger D, et al. Spinal gap junctions: potential involvement in pain
                   facilitation. J Pain 2004;5:392-405.
               74.  Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, et al. Non-stereoselective reversal of neuropathic pain by naloxone and
                   naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci 2008;28:20-9.
               75.  Milligan ED, Sloane EM, Langer SJ, Hughes TS, Jekich BM, et al. Repeated intrathecal injections of plasmid DNA encoding
                   interleukin-10 produce prolonged reversal of neuropathic pain. Pain 2006;126:294-308.
               76.  Grace PM, Hutchinson MR, Manavis J, Somogyi AA, Rolan PE. A novel animal model of graded neuropathic pain: utility to
                   investigate mechanisms of population heterogeneity. J Neurosci Methods 2010;193:47-53.
               77.  Huang D, Yu B. The mirror-image pain: an unclered phenomenon and its possible mechanism. Neurosci Biobehav Rev 2010;34:528-
                   32.
               78.  Kleinschnitz C, Brinkhoff J, Zelenka M, Sommer C, Stoll G. The extent of cytokine induction in peripheral nerve lesions depends on
                   the mode of injury and NMDA receptor signaling. J Neuroimmunol 2004;149:77-83.
               79.  Milligan ED, O’Connor KA, Nguyen KT, Armstrong CB, Twining C, et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces
                   enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 2001;21:2808-19.
               80.  Koltzenburg M, Wall PD, McMahon SB. Does the right side know what the left is doing? Trends Neurosci 1999;22:122-7.
               81.  Ruohonen S, Jagodi M, Khademi M, Taskinen HS, Ojala P, et al. Contralateral non-operated nerve to transected rat sciatic nerve
                   shows increased expression of IL-1beta, TGF-beta1, TNF-alpha, and IL-10. J Neuroimmunol 2002;132:11-7.
               82.  Wan YY, Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 2008;28:647-59.
               83.  Zheng Y, Sun L, Jiang T, Zhang D, He D, et al. TNFalpha promotes Th17 cell differentiation through IL-6 and IL-1beta produced by
                   monocytes in rheumatoid arthritis. J Immunol Res 2014;2014;2014:385352.
               84.  Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord
                   increases following a sciatic nerve constriction injury. Brain Res 1991;565:1-7.
               85.  Jiang W, Gilkeson G. Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus
                   erythematosus (SLE). J Immunother Appl 2014;1:1.
               86.  Schwarz JM, Bilbo SD. Sex, glia, and development: interactions in health and disease. Horm Behav 2012;62:243-53.
               87.  McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz)
                   2011;59:203-13.
               88.  Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol 2014;35:347-69.
               89.  Hewagama A, Patel D, Yarlagadda S, Strickland FM, Richardson BC. Stronger inflammatory/cytotoxic T-cell response in women
                   identified by microarray analysis. Genes Immun 2009;10:509-16.
               90.  Weinstein Y, Ran S, Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J
                   Immunol 1984;132:656-61.
               91.  Padi SS, Shi XQ, Zhao YQ, Ruff MR, Baichoo N, et al. Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103,
                   which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain 2012;153:95-106.
               92.  White FA, Bhangoo SK, Miller RJ. Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 2005;4:834-44.
               93.  Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, et al. Immunofluorescent spectral analysis reveals the intrathecal
                   cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from
                   allodynia. Brain Behav 2012;2:155-77.
               94.  Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA,et al. Intrathecal cannabilactone CB(2)R agonist, AM1710, controls
                   pathological pain and restores basal cytokine levels. Pain 2012;153:1091-106.
               95.  Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, et al. Interleukin-17 production in central nervous system-infiltrating T
                   cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008;172:146-55.
               96.  Li GZ, Zhong D, Yang LM, Sun B, Zhong ZH, et al. Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol
                   2005;62:481-6.
               97.  Senba E, Okamoto K, Imbe H. New Insights into Fibromyalgia. Chaper 2: Central sensitization and descending facilitation in chronic
                   pain state. Published by InTech; 2012.
               98.  Millan MJ. Descending control of pain. Prog Neurobiol 2002;66:355-474.
               99.  Xu D, Zhao H, Gao H, Zhao H, Liu D, et al. Participation of pro-inflammatory cytokines in neuropathic pain evoked by
                   chemotherapeutic oxaliplatin via central GABAergic pathway. Mol Pain 2018;14:1744806918783535.
               100.  Noor S, Sanchez JJ, Pervin Z, Sanchez JE, Sun MS, et al. Neuropathic pain susceptibility in prenatal alcohol exposed (PAE) females
                   is mediated by the proinflammatory actions of lymphocyte function-associated antigen (LFA)-1 on immune and glial cells. Peripheral
                   Mechanisms of Neuropathic Pain, Neuroscience Meeting Planner, San Diego, CA, Society for Neuroscience, 2018.
               101.  Prajeeth CK, Kronisch J, Khorooshi R, Knier B, Toft-Hansen H, et al. Effectors of Th1 and Th17 cells act on astrocytes and augment
                   their neuroinflammatory properties. J Neuroinflammation 2017;14:204.
               102.  Xie L, Yang SH. Interaction of astrocytes and T cells in physiological and pathological conditions. Brain Res 2015;1623:63-73.
   104   105   106   107   108   109   110   111   112   113   114